Long-Term Safety and Efficacy of Filgotinib Treatment for Rheumatoid Arthritis in Japanese Patients Naïve to MTX Treatment (FINCH 3).
Tatsuya AtsumiYoshiya TanakaTsukasa MatsubaraKoichi AmanoNaoki IshiguroEiji SugiyamaKunihiro YamaokaRené WesthovensDaniel W T ChingOsvaldo Daniel MessinaGerd R BurmesterMark GenoveseBeatrix BartokAlena PechonkinaAkira KondoZhaoyu YinQi GongChantal TassetTsutomu TakeuchiPublished in: Modern rheumatology (2022)
In the 56 Japanese patients treated with filgotinib, efficacy was maintained through Week 52 and beyond, with no increases in the incidence of adverse events.